ARTICLE | Company News
Biosite Diagnostics Inc., Eos Biotechnology, Medarex deal
March 5, 2001 8:00 AM UTC
Eos will use antibodies developed with BSTE’s phage-display and MEDX’s HuMAb antibody technologies to validate its genomic cancer targets. Eos will then use MEDX’s HuMAb mouse to develop therapeutic a...